The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor,...

PLoS ONE 2018 / 8 Vol. 13; Iss. 8

The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies

Faia, Kerrie, White, Kerry, Murphy, Erin, Proctor, Jennifer, Pink, Melissa, Kosmider, Nicole, McGovern, Karen, Kutok, Jeffery, Gallyas, Ferenc
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0200725
Date:
August, 2018
File:
PDF, 9.52 MB
english, 2018
Conversion to is in progress
Conversion to is failed